Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

ALDH3A1 Plays a Functional Role in Maintenance of Corneal Epithelial Homeostasis.

Koppaka V, Chen Y, Mehta G, Orlicky DJ, Thompson DC, Jester JV, Vasiliou V.

PLoS One. 2016 Jan 11;11(1):e0146433. doi: 10.1371/journal.pone.0146433. eCollection 2016.

2.

Effect of HDAC Inhibitors on Corneal Keratocyte Mechanical Phenotypes in 3-D Collagen Matrices.

Koppaka V, Lakshman N, Petroll WM.

Mol Vis. 2015 Apr 29;21:502-14. eCollection 2015.

3.

The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium.

Cai D, Zhu M, Petroll WM, Koppaka V, Robertson DM.

Am J Pathol. 2014 Oct;184(10):2662-70. doi: 10.1016/j.ajpath.2014.06.016. Epub 2014 Aug 4.

4.

Techniques for assessing 3-D cell-matrix mechanical interactions in vitro and in vivo.

Miron-Mendoza M, Koppaka V, Zhou C, Petroll WM.

Exp Cell Res. 2013 Oct 1;319(16):2470-80. doi: 10.1016/j.yexcr.2013.06.018. Epub 2013 Jun 29. Review.

5.

ALDH16A1 is a novel non-catalytic enzyme that may be involved in the etiology of gout via protein-protein interactions with HPRT1.

Vasiliou V, Sandoval M, Backos DS, Jackson BC, Chen Y, Reigan P, Lanaspa MA, Johnson RJ, Koppaka V, Thompson DC.

Chem Biol Interact. 2013 Feb 25;202(1-3):22-31. doi: 10.1016/j.cbi.2012.12.018. Epub 2013 Jan 21.

6.

Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC, Vasiliou V.

Free Radic Biol Med. 2013 Mar;56:89-101. doi: 10.1016/j.freeradbiomed.2012.11.010. Epub 2012 Nov 27. Review.

7.

Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for vision.

Chen Y, Thompson DC, Koppaka V, Jester JV, Vasiliou V.

Prog Retin Eye Res. 2013 Mar;33:28-39. doi: 10.1016/j.preteyeres.2012.10.001. Epub 2012 Oct 23. Review.

8.

Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V.

Pharmacol Rev. 2012 Jul;64(3):520-39. doi: 10.1124/pr.111.005538. Epub 2012 Apr 27. Review.

9.

Focus on molecules: ALDH1A1: from lens and corneal crystallin to stem cell marker.

Chen Y, Koppaka V, Thompson DC, Vasiliou V.

Exp Eye Res. 2012 Sep;102:105-6. doi: 10.1016/j.exer.2011.04.008. Epub 2011 Apr 23. No abstract available.

10.

Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.

Dvorak-Ewell M, Wendt D, Hague C, Christianson T, Koppaka V, Crippen D, Kakkis E, Vellard M.

PLoS One. 2010 Aug 16;5(8):e12194. doi: 10.1371/journal.pone.0012194.

11.

Dye ligand chromatography.

Gallant SR, Koppaka V, Zecherle N.

Methods Mol Biol. 2008;421:61-9.

PMID:
18826048
12.

Immunoaffinity chromatography.

Gallant SR, Koppaka V, Zecherle N.

Methods Mol Biol. 2008;421:53-60.

PMID:
18826047
13.

Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion.

Haque ME, Koppaka V, Axelsen PH, Lentz BR.

Biophys J. 2005 Nov;89(5):3183-94. Epub 2005 Sep 23.

14.

Structural analysis of lipoprotein E particles.

Schneeweis LA, Koppaka V, Lund-Katz S, Phillips MC, Axelsen PH.

Biochemistry. 2005 Sep 20;44(37):12525-34.

PMID:
16156664
15.

Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and alpha-L-iduronidase or acid alpha-glucosidase.

Prince WS, McCormick LM, Wendt DJ, Fitzpatrick PA, Schwartz KL, Aguilera AI, Koppaka V, Christianson TM, Vellard MC, Pavloff N, Lemontt JF, Qin M, Starr CM, Bu G, Zankel TC.

J Biol Chem. 2004 Aug 13;279(33):35037-46. Epub 2004 May 31.

16.

Infectious tuberculosis among newly arrived refugees in the United States.

Thorpe LE, Laserson K, Cookson S, Mills W, Field K, Koppaka VR, Oxtoby M, Maloney S, Wells C.

N Engl J Med. 2004 May 13;350(20):2105-6. No abstract available.

PMID:
15141058
17.

Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.

Murray IV, Giasson BI, Quinn SM, Koppaka V, Axelsen PH, Ischiropoulos H, Trojanowski JQ, Lee VM.

Biochemistry. 2003 Jul 22;42(28):8530-40.

PMID:
12859200
18.

Early synergy between Abeta42 and oxidatively damaged membranes in promoting amyloid fibril formation by Abeta40.

Koppaka V, Paul C, Murray IV, Axelsen PH.

J Biol Chem. 2003 Sep 19;278(38):36277-84. Epub 2003 Jun 23.

19.

Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection.

Castro KG, Jereb JA, Koppaka VR, Cohn DL.

Chest. 2003 Mar;123(3):967. No abstract available.

PMID:
12628913
20.
21.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O'Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society.

Am J Respir Crit Care Med. 2003 Feb 15;167(4):603-62. No abstract available.

PMID:
12588714
22.

Santi.

Rao JK, Koppaka VR.

Ann Intern Med. 2002 Nov 19;137(10):852-4. No abstract available.

PMID:
12435224
23.

Structural studies of discoidal lipoprotein A-I.

Koppaka V.

Cell Mol Life Sci. 2001 Jun;58(7):885-93. Review.

PMID:
11497237
24.

Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes.

Koppaka V, Axelsen PH.

Biochemistry. 2000 Aug 15;39(32):10011-6.

PMID:
10933822
25.

Lipoprotein A-I structure.

Koppaka V, Axelsen PH.

Trends Cardiovasc Med. 1999 Oct;9(7):192-5. Review.

PMID:
10881750
26.

The structure of human lipoprotein A-I. Evidence for the "belt" model.

Koppaka V, Silvestro L, Engler JA, Brouillette CG, Axelsen PH.

J Biol Chem. 1999 May 21;274(21):14541-4.

28.

Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution.

Koppaka V, Wang J, Banerjee M, Lentz BR.

Biochemistry. 1996 Jun 11;35(23):7482-91.

PMID:
8652526
29.

Insights into the complex association of bovine factor Va with acidic-lipid-containing synthetic membranes.

Cutsforth GA, Koppaka V, Krishnaswamy S, Wu JR, Mann KG, Lentz BR.

Biophys J. 1996 Jun;70(6):2938-49.

30.

Binding of bovine factor Va to phosphatidylcholine membranes.

Koppaka V, Lentz BR.

Biophys J. 1996 Jun;70(6):2930-7.

31.
32.

Fluorescence studies on erythrocyte membrane isolated from Plasmodium berghei infected mice.

Koppaka V, Sharma R, Lala AK.

Mol Cell Biochem. 1989 Nov 23-Dec 19;91(1-2):167-72.

PMID:
2622455
34.

Depth-dependent photolabelling of membrane hydrophobic core with 9-diazofluorene-2-butyric acid.

Lala AK, Dixit RR, Koppaka V.

Biochim Biophys Acta. 1989 Jan 30;978(2):333-6.

PMID:
2914144

Supplemental Content

Loading ...
Support Center